Preliminary test to evaluate the safety and efficacy of diagnosis of breast cancer with breast electromagnetic scanner

The study of evaluating the value of diagnosis of breast cancer with breast electromagnetic scanner

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023858

Enrollment

Unknown

Registered

2019-06-14

Start date

2019-07-06

Completion date

Unknown

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Gold Standard:Biopsy

Index test:Test&#32

of&#32

energy&#32

scattered&#32

electric&#32

field&#32

Eligibility

Sex/Gender

Female

Age

35 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) female, aged 35-80 years (including 35 and 80 years old); (2) patients who signed informed consent voluntarily; (3) patients who could be able to follow the research procedures and visit plans which were prescribed by the programme.

Exclusion criteria

Exclusion criteria: (1) patients with unhealed wounds in the epidermis of the contact area; (2) patients with implanted pacemakers, defibrillators and other instruments; (3) patients with breast hematoma; (4) allergic to coupling solution; (5) unable to complete the researcher according to the clinical pre-trial protocol due to severe mental or language disorders; (6) there are any other factors that unsuitable for inclusion or completion of this study.

Design outcomes

Primary

Measure	Time frame
Energy of scattered electric field;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactChen Yibei

Shenzhen ET Medical Technology Co., Ltd.

451744620@qq.com+86 15521194942

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026